Cover Image

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?

Urinary tract infections (UTIs) are extremely common and a major driver for the use of antimicrobials. Calcium fosfomycin is an old antibiotic indicated for the treatment of UTIs; however, data about its urine pharmacokinetic profile are scarce. In this work, we have evaluated the pharmacokinetics o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alicia Rodríguez-Gascón (Author), Ana Alarcia-Lacalle (Author), María Ángeles Solinís (Author), Ana del Pozo-Rodríguez (Author), Zuriñe Abajo (Author), María Cabero (Author), Andrés Canut (Author), Arantxa Isla (Author)
Format:	Book
Published:	MDPI AG, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimizing Antibiotic Therapy for <i>Stenotrophomonas maltophilia</i> Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach
by: Helena Barrasa, et al.
Published: (2024)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
by: Ana Alarcia-Lacalle, et al.
Published: (2021)

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
by: Alicia Rodríguez-Gascón, et al.
Published: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
by: Alicia Rodríguez-Gascón, et al.
Published: (2021)

α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
by: Julen Rodríguez-Castejón, et al.
Published: (2021)

<i>Pseudomonas aeruginosa</i> Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis
by: Ana Valero, et al.
Published: (2021)

Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in <i>Neisseria gonorrhoeae</i>
by: Urša Gubenšek, et al.
Published: (2022)

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
by: Idoia Bilbao-Meseguer, et al.
Published: (2021)

Fosfomycin Pharmacokinetic Profile in Plasma and Urine and Quantitative Estimation in Prostate and Seminal Vesicles after One and Two Consecutive Doses of Oral Fosfomycin Trometamol in Healthy Male Volunteers
by: Andrea F. D. Di Stefano, et al.
Published: (2022)

Development and application of neonatal physiology‐based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment
by: Christopher A. Darlow, et al.
Published: (2024)

Is Provision of Healthcare Sufficient to Ensure Better Access? An Exploration of the Scope for Public-Private Partnership in India
by: Sabitri Dutta, et al.
Published: (2015)

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination
by: Guillermo Martín-Gutiérrez, et al.
Published: (2020)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
by: Antonio Sorlozano-Puerto, et al.
Published: (2020)

Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
by: Marina Beraza-Millor, et al.
Published: (2023)

Effect of Glycerol on Fosfomycin Activity against <i>Escherichia coli</i>
by: Miriam Ortiz-Padilla, et al.
Published: (2022)

Acidic Urine pH and Clinical Outcome of Lower Urinary Tract Infection in Kidney Transplant Recipients Treated with Ciprofloxacin and Fosfomycin
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
by: Alexandro Rodríguez-Rojas, et al.
Published: (2013)

Effect of Fosfomycin on Cyclosporine Nephrotoxicity
by: Juan Antonio Ortega-Trejo, et al.
Published: (2020)

Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
by: Pascal André, et al.
Published: (2022)

Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability
by: Oskar Estradé, et al.
Published: (2022)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
by: Anneke Corinne Dijkmans, et al.
Published: (2017)

Fosfomycin-Overcoming Problematic In Vitro Susceptibility Testing and Tricky Result Interpretation: Comparison of Three Fosfomycin Susceptibility Testing Methods
by: Jan Závora, et al.
Published: (2024)

Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production
by: Mónica Vicente-Pascual, et al.
Published: (2020)

Acute localized exanthematous pustulosis induced by fosfomycin
by: Ibrahim Alfuraih, MD, et al.
Published: (2023)

Fosfomycin: the characteristics, activity, and use in critical care
by: Hashemian SMR, et al.
Published: (2019)

How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers
by: Hui Liu, et al.
Published: (2022)

Tissue Levels of Flurbiprofen in the Rat Plantar Heel after Short-Duration Topical Iontophoresis Are Sufficient to Induce Pharmacodynamic Responses to Local Pain Stimuli
by: Yilu Cai, et al.
Published: (2020)

Fosfomycin: An old antibiotic and new perspectives. A review
by: Marina V. Leonova
Published: (2023)

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation
by: Itziar Gómez-Aguado, et al.
Published: (2021)

Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> with Canine Ex Vivo Modeling: A Pilot Study
by: Kazuki Harada, et al.
Published: (2020)

Fosfomycin Resistance in <i>Escherichia coli</i> Isolates from South Korea and <i>in vitro</i> Activity of Fosfomycin Alone and in Combination with Other Antibiotics
by: Hyeri Seok, et al.
Published: (2020)

Risk-pooling: necessary but not sufficient?
by: Davies Philip, et al.
Published: (2001)

Risk-pooling: necessary but not sufficient?
by: Philip Davies, et al.

Rediscovering fosfomycin in its 50th anniversary (1969-2019)
by: Pedro Romero Pérez
Published: (2020)

Fosfomycin susceptibility testing and resistance mechanisms in Enterobacterales in South Africa
by: Jessica S. Hurwitz, et al.
Published: (2024)

Fosfomycin an Alternative for the Treatment of Methicillin Resistant Staphylococcus aureus (MRSA)
by: U M Ibrahim
Published: (2020)

Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study
by: Christina König, et al.
Published: (2023)

Assessing the Influence of Urine pH on the Efficacy of Ciprofloxacin and Fosfomycin in Immunocompetent and Immunocompromised Murine Models of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Infection in the Lower Urinary Tract
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Fosfomycin: Still a Competent Treatment Option in Urinary Tract Infections
by: Paul Grama, et al.
Published: (2020)

Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin
by: Maria Baltogianni, et al.
Published: (2024)